PHARMA
ASLAN Closes Series C Financing Round Of US$43 Million
The additional investment of US$9 million will enable ASLAN to develop its licensing agreement for the rheumatoid arthritis drug LAS186323.
Eisai Acquires Chinese Generics Company Liaoning TianYi
The acquisition of Liaoning gives Eisai a foothold in China's generics sector which accounts for 80 percent of the country's pharmaceutical market.
Cipla Launches Hepcvir-L For HepC Genotype 1 Patients
Hepcvir-L will be provided to patients in India at the fraction of the cost of branded Ledipasvir-Sofosbuvir under a licensing agreement with Gilead Sciences Inc.
Samsung BioLogics to Construct World’s Largest Biopharmaceutical Manufacturing Plant
Samsung BioLogics' US$724 million plant is set to begin operations in the fourth quarter of 2018.
First Dengue Vaccine In Asia Approved In The Philippines
Dengvaxia®, the world's first dengue vaccine, has been approved for use in the Philippines.
AstraZeneca Expands Presence in Asia With Deals in China and Japan
AstraZeneca has entered a strategic alliance with WuXi AppTech and acquired Takeda's respiratory business.
ASLAN Raises US$34 Million For Immuno-Oncology
The US$34 million in Series C funding will be used to complete at least ten clinical studies for ASLAN's lead compound, ASLAN001.
Fosun And Wenzhou TCM Hospital To Establish Geriatrics Hospital
Fosun Pharma and Wenzhou TCM hospital have joined hands to open a geriatrics hospital to help cope with the area's rapidly aging population.
Teva & Takeda Enter Joint Venture For Generics In Japan
Asia's largest pharmaceutical company has entered a partnership with Teva to provide generic drugs to Japan.
